These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19527762)

  • 21. Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor.
    Gupta A; Sinnott P
    Hum Immunol; 2009 Aug; 70(8):618-22. PubMed ID: 19374932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of the virtual crossmatch in solid organ transplantation.
    Amico P; Hönger G; Steiger J; Schaub S
    Curr Opin Organ Transplant; 2009 Dec; 14(6):656-61. PubMed ID: 19741534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The repercussions of implementing flow cytometry as a single HLA antibody screening technique in prospective renal transplant recipients.
    Magee B; Martin J; Middleton D
    Transpl Int; 2006 Feb; 19(2):105-9. PubMed ID: 16441358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical cytometry and progress in HLA antibody detection.
    Bray RA; Tarsitani C; Gebel HM; Lee JH
    Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assignment of C1q-binding HLA antibodies as unacceptable HLA antigens avoids positive CDC-crossmatches prior to transplantation of deceased donor organs.
    Juhl D; Marget M; Hallensleben M; Görg S; Ziemann M
    Transpl Immunol; 2017 Mar; 41():17-21. PubMed ID: 28088367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor-specific HLA antibodies in predicting crossmatch outcome: Comparison of three different laboratory techniques.
    Peräsaari JP; Jaatinen T; Merenmies J
    Transpl Immunol; 2018 Feb; 46():23-28. PubMed ID: 29157597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebulous humors: defining alloantibodies in the 21st century.
    Warner P
    Hum Immunol; 2009 Aug; 70(8):623-6. PubMed ID: 19374934
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
    Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S
    Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crossmatch procedures used in organ transplantation.
    Gebel HM; Lebeck LK
    Clin Lab Med; 1991 Sep; 11(3):603-20. PubMed ID: 1934966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach.
    Poli F; Cardillo M; Scalamogna M
    Hum Immunol; 2009 Aug; 70(8):631-5. PubMed ID: 19527758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.
    Reinsmoen NL; Lai CH; Vo A; Cao K; Ong G; Naim M; Wang Q; Jordan SC
    Transplantation; 2008 Sep; 86(6):820-5. PubMed ID: 18813107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay.
    Visentin J; Bachelet T; Borg C; Franchini N; Nong T; Lee JH; Couzi L; Merville P; Guidicelli G; Taupin JL
    Transplantation; 2017 Mar; 101(3):624-630. PubMed ID: 27336398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation.
    Zeevi A; Lunz JG; Shapiro R; Randhawa P; Mazariegos G; Webber S; Girnita A
    Hum Immunol; 2009 Aug; 70(8):645-50. PubMed ID: 19527760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML; Smith JD
    Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transnational validation of the Australian algorithm for virtual crossmatch allocation in kidney paired donation.
    Böhmig GA; Fidler S; Christiansen FT; Fischer G; Ferrari P
    Hum Immunol; 2013 May; 74(5):500-5. PubMed ID: 23380140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
    Gloor JM; Moore SB; Schneider BA; Degoey SR; Stegall MD
    Transplantation; 2007 Jul; 84(2):258-64. PubMed ID: 17667819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system.
    Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K
    Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The changing role of antibody testing in transplantation.
    Leffell MS; Montgomery RA; Zachary AA
    Clin Transpl; 2005; ():259-71. PubMed ID: 17424745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.